You have searched for "Boustead"
Showing 1081-1090 of 1112
Majority of LTAT’s position assessment findings unearthed financial irregularities and weaknesses
PETALING JAYA: The Armed Forces Fund Board (LTAT) has completed its position assessment for the financial year 2017 (FY17) and FY18 ended Dec 31, revealing significant financial irregularities and weaknesses
Increasingly, it would appear that the chief executive of the Armed Forces Fund Board (LTAT) Nik Amlizan Mohamed (pic) has been handed a poison chalice upon taking over the fund last year.
KUALA LUMPUR: The armed forces fund board (LTAT) said that there was no element of criminal intent when the retirement fund had discovered discrepancies with its accounts earlier.
KUALA LUMPUR: The crude palm oil (CPO) futures contract on Bursa Malaysia Derivatives is expected to go through correction next week, but will be well supported at between RM2,350 and RM2,400 per tonne for the CPO benchmark month.
PETALING JAYA: The share price of Pharmaniaga Bhd recorded the strongest surge in 12 months led by temporary contract extension optimism, which Kenanga Research views as a “short-term reprieve” for the integrated pharmaceutical group.
PETALING JAYA: Plantation heavyweights saw their share price jump as crude palm oil (CPO) prices continued to rally, and as investors bet on improved earnings from the companies in the coming quarters.
KUALA LUMPUR, Nov 21 (Bernama) -- Boustead Plantations Bhd’s net loss had widened to RM34.31 million in the third quarter ended Sept 30, 2019 from RM21.89 million in the same quarter last year, mainly due to higher amortisation and finance costs.
PETALING JAYA: Boustead Plantations Bhd saw its net loss widening to RM34.31mil in the third quarter ended Sept 30 from RM21.89mil in the previous corresponding quarter on higher amortisation and finance costs.
KUALA LUMPUR: Stocks to watch for on Friday include Ekovest Bhd, Boustead Plantations, Malaysian Resources Corp Bhd’s (MRCB), WCT Holdings Bhd, Hibiscus Petroleum Bhd and Deleum Bhd, according to JF Apex Research.